Equities
European Equities Mixed in Friday Trading; Novo Nordisk Says Ziltivekimab Fails to Reduce Major Adverse Cardiovascular Events in Trial – Yahoo Finance
Related Articles
Kelly Park Capital streamlines private market access with PRISM 2.0
New 5-in-1 onboarding tool aims to cut subscription paperwork as advisor demand...
Using Buffered ETFs to Manage Downside Risk in Equities
Host Ryan Nauman speaks with Charles Champagne, Head of ETF Strategy at...
BigBear.ai Stock Flat Following Q2 Revenue Beat and Backlog Growth – BigBear.ai Holdings (NYSE:BBAI)
What Catalyzed BigBear.ai’s Stock Movement?BigBear.ai posted a second-quarter loss of 5 cents...
Earnings call transcript: Ares Management tops revenue forecasts in Q2 2026 By Investing.com
Ares Management reported second-quarter 2026 revenue of $1.43 billion, above Wall Street’s...
Leave a comment